Primary |
Gout |
22.2% |
Familial Mediterranean Fever |
13.9% |
Suicide Attempt |
11.1% |
Gouty Arthritis |
8.3% |
Back Pain |
5.6% |
Behcet's Syndrome |
5.6% |
Completed Suicide |
5.6% |
Drug Use For Unknown Indication |
5.6% |
Hyperlipidaemia |
5.6% |
Upper Respiratory Tract Infection |
5.6% |
Accident |
2.8% |
Bursitis |
2.8% |
Hypercholesterolaemia |
2.8% |
Neck Pain |
2.8% |
|
Rhabdomyolysis |
16.7% |
Vomiting |
10.0% |
Drug Toxicity |
6.7% |
Polyneuropathy |
6.7% |
Renal Failure Acute |
6.7% |
Splenomegaly |
6.7% |
Acute Promyelocytic Leukaemia |
3.3% |
Intentional Overdose |
3.3% |
Medication Error |
3.3% |
Metabolic Acidosis |
3.3% |
Multi-organ Failure |
3.3% |
Optic Neuropathy |
3.3% |
Pancreatitis Acute |
3.3% |
Partial Seizures |
3.3% |
Rectal Haemorrhage |
3.3% |
Sepsis |
3.3% |
Shock |
3.3% |
Tachycardia |
3.3% |
Therapeutic Agent Toxicity |
3.3% |
White Blood Cell Count Increased |
3.3% |
|
Secondary |
Product Used For Unknown Indication |
20.7% |
Gout |
18.4% |
Drug Use For Unknown Indication |
9.2% |
Sedation |
8.0% |
Polymyositis |
6.9% |
Hyperlipidaemia |
5.7% |
Immunosuppression |
4.6% |
Familial Mediterranean Fever |
3.4% |
Gouty Arthritis |
3.4% |
Pneumonia |
3.4% |
Heart Transplant |
2.3% |
Helicobacter Gastritis |
2.3% |
Hypercholesterolaemia |
2.3% |
Prophylaxis |
2.3% |
Amyloidosis |
1.1% |
Angina Pectoris |
1.1% |
Helicobacter Infection |
1.1% |
Muscular Weakness |
1.1% |
Osteoarthritis |
1.1% |
Renal Amyloidosis |
1.1% |
|
Weight Decreased |
15.6% |
Vomiting |
12.5% |
Rhabdomyolysis |
9.4% |
Pyrexia |
6.3% |
Renal Failure Acute |
6.3% |
Sepsis |
6.3% |
Agranulocytosis |
3.1% |
Atelectasis |
3.1% |
Blood Creatinine Increased |
3.1% |
Eosinophilia |
3.1% |
Febrile Neutropenia |
3.1% |
General Physical Health Deterioration |
3.1% |
Neutropenia |
3.1% |
Oedema |
3.1% |
Peripheral Sensory Neuropathy |
3.1% |
Sensorimotor Disorder |
3.1% |
Septic Shock |
3.1% |
Stevens-johnson Syndrome |
3.1% |
Thrombocytopenia |
3.1% |
Troponin T Increased |
3.1% |
|
Concomitant |
Prophylaxis Against Transplant Rejection |
12.8% |
Multiple Myeloma |
10.6% |
Renal Transplant |
9.6% |
Neuropathy Peripheral |
6.4% |
Pulmonary Hypertension |
6.4% |
Depression |
5.3% |
Neuralgia |
5.3% |
Pain |
5.3% |
Diabetes Mellitus |
4.3% |
Drug Use For Unknown Indication |
4.3% |
Ill-defined Disorder |
4.3% |
Skin Ulcer |
4.3% |
Type 2 Diabetes Mellitus |
4.3% |
Hypertension |
3.2% |
Osteoporosis |
3.2% |
Bronchopulmonary Aspergillosis |
2.1% |
Dementia |
2.1% |
Diabetic Neuropathy |
2.1% |
Metastatic Renal Cell Carcinoma |
2.1% |
Nephrogenic Anaemia |
2.1% |
|
Pain |
11.6% |
Pyrexia |
9.3% |
Vomiting |
9.3% |
Weight Increased |
9.3% |
Jaundice |
4.7% |
Kidney Transplant Rejection |
4.7% |
Pruritus |
4.7% |
Reflux Oesophagitis |
4.7% |
Respiratory Failure |
4.7% |
Staphylococcal Infection |
4.7% |
Status Epilepticus |
4.7% |
Unresponsive To Stimuli |
4.7% |
Viral Infection |
4.7% |
Visual Disturbance |
4.7% |
Atrial Fibrillation |
2.3% |
Blood Pressure Increased |
2.3% |
Catheter Related Infection |
2.3% |
Coma |
2.3% |
Condition Aggravated |
2.3% |
Diarrhoea |
2.3% |
|